Heart CenterHome > Specialties > Heart Center > Warfarin Therapy study
Warfarin Therapy study
Regions Hospital participates in Warfarin Therapy Study
Warfarin is often prescribed to patients who have atrial fibrillation or a risk for forming clots. Many patients who are having a pacemaker or defibrillator implanted are on warfarin therapy. The Regions Hospital Heart Center developed a study published in Heart Rhythm Journal to determine whether continuing warfarin therapy while undergoing a pacemaker or defibrillator implantation was beneficial to the patient.
Researchers found that patients who continued taking warfarin had a lower incidence of bleeding such as forming a pocket hematoma (a collection of blood outside of a blood vessel). Patients also had a shorter hospital stay than those who stopped warfarin therapy for their procedure.
The study concluded that continuing warfarin therapy appears to be a safe and cost-effective approach for patients undergoing a pacemaker or defibrillator implantation and in patients with moderate to high blood clot risk. The study was supported in part by “Discovery Grants” from the HealthPartners Research Foundation.
Make an appointment651-254-4887
Find a doctorOur staff includes 700 HealthPartners providers.